NCT06450171View on ClinicalTrials.gov

Evaluation of Multi-Cancer Early Detection Testing in a High-Risk Population: The INFORM Study

NARecruitingINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

September 27, 2024

Primary Completion Date

January 31, 2027

Study Completion Date

January 31, 2028

Conditions
Cancer Predisposition SyndromePredisposition, Genetic
Interventions
OTHER

GRAIL Galleri Test

A multi-cancer early detection (MCED) blood test.

Trial Locations (1)

02215

RECRUITING

Dana-Farber Cancer Institute, Boston

All Listed Sponsors
lead

Dana-Farber Cancer Institute

OTHER